Approval Pathway for Biosimilar and Interchangeable Biological Products; Hearing
Document ID: FDA-2010-N-0477-0001
Comments
Total: 70
-
LG Life Sciences, Ltd. - Comment
Posted : 11/09/2010 ID :FDA-2010-N-0477-0003 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Sobel Medical Associates, Ltd. - Comment
Posted : 11/09/2010 ID :FDA-2010-N-0477-0004 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
The AIDS Institute - Comment
Posted : 11/09/2010 ID :FDA-2010-N-0477-0005 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Consumers Union - Comment
Posted : 11/09/2010 ID :FDA-2010-N-0477-0009 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Consumers Union - Comment
Posted : 11/09/2010 ID :FDA-2010-N-0477-0010 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
NORTHEASTERN UNIVERSITY - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0013 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
TLG Consulting Inc. - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0014 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Genzyme Corporation - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0015 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
GlaxoSmithKline - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0016 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Genentech, Inc. - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0017 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American Academy of Dermatology Association - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0018 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
National Hemophilia Foundation - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0019 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
EuropaBio & EBE - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0020 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Watson Laboratories, Inc. - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0021 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
European Generic medicines Association (EGA) - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0022 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
United States Pharmacopeial Convention - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0023 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Novo Nordisk Inc. - Comment
Posted : 12/21/2010 ID :FDA-2010-N-0477-0024 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Merck & Co. - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0025 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Bristol-Myers Squibb Company - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0026 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Academy of Managed Care Pharmacy (AMCP) - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0027 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American Plasma Users Coalition - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0028 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Momenta Pharmaceuticals Inc. - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0029 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
American College of Rheumatology - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0030 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Pfizer Inc - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0031 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
National Kidney Foundation - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0032 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
PPTA - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0033 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
National Association of Chain Drug Stores (NACDS) - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0034 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
The Biotechnology Industry Organization (BIO) - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0035 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Pharmaceutical Research and Manufacturers of America (PhRMA) - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0036 Agency : FDA -
Dec 31,2010 11:59 PM ET
-
Johnson & Johnson - Comment
Posted : 12/27/2010 ID :FDA-2010-N-0477-0037 Agency : FDA -
Dec 31,2010 11:59 PM ET